tiprankstipranks
Trending News
More News >
Turn Therapeutics Inc (TTRX)
NASDAQ:TTRX
US Market

Turn Therapeutics Inc (TTRX) Financial Statements

Compare
19 Followers

Turn Therapeutics Inc Financial Overview

Turn Therapeutics Inc's market cap is currently $110.42M. The company's EPS TTM is $; its P/E ratio is -27.95; Turn Therapeutics Inc is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23
Income Statement
Total Revenue$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00
Operating Income$ -1.80M$ -2.31M
EBITDA$ -1.75M$ -2.26M
Net Income$ -1.77M$ -2.29M
Balance Sheet
Cash & Short-Term Investments$ 872.60K$ 1.18M
Total Assets$ 2.05M$ 2.01M
Total Debt$ 121.04K$ 25.16K
Net Debt$ -751.56K$ -1.16M
Total Liabilities$ 2.23M$ 1.93M
Stockholders' Equity$ -177.43K$ 85.77K
Cash Flow
Free Cash Flow$ -1.46M$ -1.42M
Operating Cash Flow$ -1.36M$ -1.38M
Investing Cash Flow$ -99.47K$ -44.31K
Financing Cash Flow$ 1.15M$ 500.00K
Currency in USD

Turn Therapeutics Inc Earnings and Revenue History

Turn Therapeutics Inc Debt to Assets

Turn Therapeutics Inc Cash Flow

Turn Therapeutics Inc Forecast EPS vs Actual EPS